If there was ever a year that microarray technology went mainstream, it was 2013. And though firms had targeted it for years, it wasn't the clinical market where arrays impacted the average person's life, but the direct-to-consumer genomics market, particularly via genetic genealogy and ancestry testing services.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.